Skip to content
‹ Back to IndustriesHealthcare

CooperVision Specialty Eye Care Aims to Boost Fitting Confidence through New Educational Resources

SAN RAMON, Calif., May 7, 2021—CooperVision Specialty Eye Care is committed to providing ongoing education for eye care professionals by offering an ongoing series of minute videos, as well as educational webinars. Focused on either myopia management or scleral lens fitting, the video series and webinars are aimed at boosting ECP confidence with Paragon CRT® lenses…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from CooperVision on MarketScale.

·
Share
CooperVision Specialty Eye Care Aims to Boost Fitting Confidence through New Educational Resources

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

SAN RAMON, Calif., May 7, 2021—CooperVision Specialty Eye Care is committed to providing ongoing education for eye care professionals by offering an ongoing series of minute videos, as well as educational webinars. Focused on either myopia management or scleral lens fitting, the video series and webinars are aimed at boosting ECP confidence with Paragon CRT® lenses and Onefit™ scleral lenses, designed by Blanchard, by providing tips for fitting, consultation, and practice management.

“Our new resources are designed to provide eye care professionals (ECP) with the information they need and education they want as they build and grow their specialty lens capabilities,” said Juan Carlos Aragon, president, CooperVision Specialty Eye Care. “We view all ECPs who prescribe our specialty contact lenses as partners. As such, we want to provide them with world class support and invest in their success.”

Minute Video Series

The Minute series delivers concise, minute-long video segments filled with valuable information designed to maximize an ECP’s effectiveness. “The Myopia Minute” for Paragon CRT® and “The Onefit™ Minute” for Blanchard scleral lenses aim to build ECP knowledge and fitting confidence with insider tips and techniques from the industry’s leading ortho-K and scleral lens experts.

The first four Minute videos are now live featuring Dr. Kelly Voltz, OD, FAAO, FSLS, Senior Manager, Professional and Academic Affairs, CooperVision Specialty EyeCare, as well as Leah Johnson, OD, FAAO, FSLS, Director of Professional Affairs, CooperVision Specialty EyeCare. Myopia Minutes can be found here, while Onefit™ Minutes can be viewed here.

Webinar Series

CooperVision Specialty Eye Care will host one webinar per month throughout the remainder of the year. Each webinar will be presented by an ortho-K or scleral lens expert. Upcoming webinar topics and timeline are as follows:

  • May: Toric Haptics & Quadrant Specific Landing Zones with Onefit™ MED & Onefit™ MED+
  • June: Paragon CRT® Fitting Software
  • July: Stand Out and Change Lives with Paragon CRT®
  • August: Fit Like a Pro with Paragon CRT®
  • September: How to Grow Your Practice with the Onefit™ Family of Scleral Lenses
  • October: Decentered Multifocal Optics with Onefit™ MED and Onefit™ MED+ Scleral Lenses
  • November: Instrument Driven Fitting – Using OCT to Customize Your Fit
  • December: Insider Tips and Techniques for Successfully Presenting Paragon CRT® to Your Patients.

To receive webinar registration information and the weekly Minute videos, sign up for email communications here.

# # #

About CooperVision
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of soft contact lenses. The Company produces a full array of daily disposable, two-week and monthly contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges such as astigmatism, presbyopia and childhood myopia; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.

About CooperCompanies
CooperCompanies (“Cooper”) is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.

Media Contact
Jamie Palmeroni-Lavis, McDougall Communications
jamie@mcdougallpr.com or +1-585-478-4338

CooperVision

Part of this channel

CooperVision

News, updates, and expert insights from CooperVision.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

LeanTaaS buys LookDeep Health and brings computer vision into hospital patient rooms

LeanTaaS buys LookDeep Health and brings computer vision into hospital patient rooms

LeanTaaS said on November 3 it acquired LookDeep Health, a computer vision company, and introduced iQueue for Virtual Care, its first product built on what it calls ambient intelligence. Terms were not disclosed. The product bundles Virtual Observation, Virtual Nursing and Virtual Medicine, and LeanTaaS says hospitals can build on compatible cameras and in-room devices already installed or deploy supported hardware. The company cited reported results from LookDeep deployments, including fall-rate reductions of more than 70%, and said LookDeep's technology was evaluated in peer-reviewed research published in Frontiers in Imaging.

  • 01LeanTaaS acquired LookDeep Health and launched iQueue for Virtual Care, combining Virtual Observation, Virtual Nursing and Virtual Medicine; acquisition terms were not disclosed.
  • 02Hospitals can build on compatible cameras and in-room devices already in place or deploy supported hardware, according to LeanTaaS, which did not name camera vendors.
  • 03LeanTaaS reported results from LookDeep deployments including fall-rate reductions of more than 70% and twice as much nursing contact, figures that are the company's own and not tied to named health systems.

Nov 3, 2026

Philips posts 8% order intake growth in Q3 and books a EUR 288 million Respironics provision

Philips posts 8% order intake growth in Q3 and books a EUR 288 million Respironics provision

Royal Philips reported 8% comparable order intake growth for the third quarter of 2026, driven by Diagnosis & Treatment, with comparable sales up 3% to EUR 4.4 billion and an adjusted EBITA margin of 13.0%, up 70 basis points. The company reiterated its 2026 outlook for 3% to 4.5% comparable sales growth. Philips Respironics reached an agreement in principle with the US Department of Justice to resolve previously disclosed investigations related to its recall, and Philips recorded a EUR 288 million provision in the quarter, with payment expected in the first quarter of 2027 subject to final documentation.

  • 01Comparable order intake grew 8%, matching a year earlier, with Diagnosis & Treatment the driver; the equipment order book stands at about 40% of revenue.
  • 02Comparable sales rose 3% to EUR 4.4 billion, adjusted EBITA margin reached 13.0%, and free cash flow was EUR 384 million; the 2026 outlook was reiterated.
  • 03Philips Respironics reached an agreement in principle with the DOJ on previously disclosed recall investigations, and Philips recorded a EUR 288 million provision; the settlement is subject to final documentation.

Nov 3, 2026

Rockwell Medical agrees to buy most of Vantive's hemodialysis business for $125 million

Rockwell Medical agrees to buy most of Vantive's hemodialysis business for $125 million

Rockwell Medical agreed to acquire most of Vantive's hemodialysis business for $125 million in base consideration, plus up to $45 million in contingent payments, with closing expected mid-2027. The deal includes hemodialysis concentrates, machines, water treatment systems, and Vantive's Medolla, Italy manufacturing facility; the combined business could generate $400-450 million annually, depending on various factors.

  • 01Rockwell Medical acquires Vantive's hemodialysis concentrates, AK 98 machines, water treatment systems, and one-million-square-foot Medolla, Italy manufacturing campus for $125 million base price plus up to $45 million contingent on revenue and EBITDA milestones.
  • 02Combined business targeted to generate $400-450 million in annual revenue depending on operating performance, exchange rates, market conditions and integration.
  • 03Vantive's dialyzer portfolio, including Theranova dialyzer for expanded hemodialysis, remains with Vantive; the company will focus on home dialysis and critical care after divestiture.

Nov 3, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512